CEB-01 by Cebiotex for Soft Tissue Sarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Soft Tissue Sarcoma.

Researchers investigate the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma

Researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma.

July 31, 2023

Opinion | Dark Humor Allows Us to See the ‘Light’ in Medicine

Lazarus is an adjunct professor of psychiatry. During a visit to our daughter and her family in Columbus, Ohio, my wife and I went grocery

November 4, 2024

Prelude and AbCellera jump on the ADC train with partnership – Pharmaceutical Technology

Prelude will be responsible for the clinical development and global commercialisation while AbCellera will lead the manufacturing activities for the ADCs. Image Credit: Alpha Tauri

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.